[go: up one dir, main page]

KR930008138A - 특정한 뉴클레오티드 시퀀스를 포함하는 약독화(弱毒化)된 홍역 백신 바이러스 균주와 그의 완벽한 동정 방법 - Google Patents

특정한 뉴클레오티드 시퀀스를 포함하는 약독화(弱毒化)된 홍역 백신 바이러스 균주와 그의 완벽한 동정 방법 Download PDF

Info

Publication number
KR930008138A
KR930008138A KR1019920003759A KR920003759A KR930008138A KR 930008138 A KR930008138 A KR 930008138A KR 1019920003759 A KR1019920003759 A KR 1019920003759A KR 920003759 A KR920003759 A KR 920003759A KR 930008138 A KR930008138 A KR 930008138A
Authority
KR
South Korea
Prior art keywords
measles vaccine
vaccine virus
specific nucleotide
nucleotide sequences
complete identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019920003759A
Other languages
English (en)
Other versions
KR950012759B1 (ko
Inventor
게이꼬 사사끼
다까유끼 모리
사또시 마끼노
Original Assignee
오무라 사또시
기다사또 겐규소(샤당호징)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오무라 사또시, 기다사또 겐규소(샤당호징) filed Critical 오무라 사또시
Publication of KR930008138A publication Critical patent/KR930008138A/ko
Application granted granted Critical
Publication of KR950012759B1 publication Critical patent/KR950012759B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

홍역 백신의 종자 바이러스 또는 홍역 바이러스 백신에서 15894개의 뉴클레오티드로 이루어진 바이러스 게놈 RNA로 이루어진 특정 뉴클레오티드 시퀀스를 포함하는 홍역 백신 바이러스 AIK-C 균주를 제공한 것이다.

Description

특정한 뉴클레오티드 시퀀스를 포함하는 약독화(弱毒化)된 홍역 백신 바이러스 균주와 그의 완벽한 동정 방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도 c DNA 구성의 아우트라인,
제2도 AIK-C의 지도
제3도 상보적게놈 RNA로서 합성올리고 뉴클레오티드의 게놈 DNA 스퀀스.

Claims (54)

  1. 홍역 바이러스 백신과 종자 바이러스에서 하기 시퀀스의 15894개의 뉴클레오티드로 이루어진 전체 바이러스 게놈 RNA으로 이루어진 특정 뉴클레오티드 시퀀스를 포함하는 홍역백신 바이러스 균주
  51. 제1항에 있어서, 돌연변이 시퀀스 또는 손상된 시퀀스의 부분적인 첨가를 가지는 뉴클레오티드 시퀀스로 이루어진 바이러스 게놈 RNA로 구성되는 홍역 백신 바이러스.
  52. 홍역 백신 바이러스 균주의 게놈 RNA 중에서 제1항에 의한 15894개의 뉴클레오티드로 이루어진 특정 뉴클레오티드 시퀀스를 탐지하는 것으로 이루어진 홍역 백신 바이러스 균주에 대한 완벽한 동정 방법.
  53. 제3항에 있어서, 완벽한 동정 방법은 노던 블릇 테크닉과 폴리머레이즈 체인 반응 방법으로 바이러스 게놈 RNA의 뉴클레오티드 시퀀스의 부분을 검출하는 것이 특징인 동정 방법.
  54. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920003759A 1991-10-14 1992-03-07 특정 염기 배열을 포함하는 약독화(弱毒化)된 홍역 백신 바이러스주 및 그의 절대적 동정법 Expired - Lifetime KR950012759B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP91-293625 1991-10-14
JP3293625A JP3045581B2 (ja) 1991-10-14 1991-10-14 麻疹ワクチンウイルス株同定方法
JP293625 1991-10-14

Publications (2)

Publication Number Publication Date
KR930008138A true KR930008138A (ko) 1993-05-21
KR950012759B1 KR950012759B1 (ko) 1995-10-21

Family

ID=17797135

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920003759A Expired - Lifetime KR950012759B1 (ko) 1991-10-14 1992-03-07 특정 염기 배열을 포함하는 약독화(弱毒化)된 홍역 백신 바이러스주 및 그의 절대적 동정법

Country Status (10)

Country Link
US (2) US5654136A (ko)
EP (1) EP0540135B1 (ko)
JP (1) JP3045581B2 (ko)
KR (1) KR950012759B1 (ko)
AT (1) ATE193726T1 (ko)
DE (1) DE69231143T2 (ko)
DK (1) DK0540135T3 (ko)
ES (1) ES2148164T3 (ko)
GR (1) GR3034278T3 (ko)
PT (1) PT540135E (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2133339A1 (en) * 1992-04-08 1993-10-09 Jennifer S. Rota Wild-type measles virus glycoproteins: vaccine and detection method therefor
US6638482B1 (en) * 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
AU4452897A (en) * 1996-07-31 1998-02-25 Claude P. Muller Peptides
BR9712138A (pt) * 1996-09-27 2000-01-18 American Cyanamid Co Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição.
CA2262500C (en) 1997-06-04 2004-03-16 The Research Foundation For Microbial Diseases Of Osaka University Measles virus mutant antigen and gene coding for the same
EP1064358A2 (en) * 1998-03-26 2001-01-03 American Cyanamid Company Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
AU781005B2 (en) * 1999-11-19 2005-04-28 Daiichi Sankyo Company, Limited Method for producing cell-fusion type morbillivirus mutant
US6653069B2 (en) 2000-01-31 2003-11-25 The Research Foundation For Microbial Diseases Of Osaka University Method for quality control of an attenuated vericella live vaccine
AU2000279480B2 (en) * 2000-02-10 2006-08-03 Daiichi Sankyo Company, Limited Methods for producing temperature-sensitive morbillivirus
EP1375512B1 (en) * 2002-06-20 2009-07-22 Institut Pasteur Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions
EP1375670B1 (en) 2002-06-20 2013-06-12 Institut Pasteur Recombinant measles viruses expressing epitopes of antigens of RNA viruses and use of the recombinant viruses for the preparation of vaccine compositions
CA2432738A1 (en) 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
EP2420242A1 (en) 2010-08-20 2012-02-22 Lauer, Ulrich M. Oncolytic measles virus
CN104211769B (zh) * 2013-05-30 2018-08-03 中国科学院过程工程研究所 一种小分子抗体亲和肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617261A (en) * 1984-03-21 1986-10-14 Cetus Corporation Process for labeling nucleic acids and hybridization probes
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses

Also Published As

Publication number Publication date
JP3045581B2 (ja) 2000-05-29
KR950012759B1 (ko) 1995-10-21
EP0540135A2 (en) 1993-05-05
US5824777A (en) 1998-10-20
DE69231143D1 (de) 2000-07-13
US5654136A (en) 1997-08-05
DK0540135T3 (da) 2000-08-07
DE69231143T2 (de) 2000-10-19
ATE193726T1 (de) 2000-06-15
PT540135E (pt) 2000-11-30
GR3034278T3 (en) 2000-12-29
EP0540135A3 (en) 1993-12-08
EP0540135B1 (en) 2000-06-07
ES2148164T3 (es) 2000-10-16
JPH05103665A (ja) 1993-04-27

Similar Documents

Publication Publication Date Title
Furuichi “Methylation-coupled” transcription by virus-associated transcriptase of cytoplasmic polyhedrosis virus containing double-stranded RNA
Kingham et al. Identification of avian infectious bronchitis virus by direct automated cycle sequencing of the S-1 gene
Le Guyader et al. Evaluation of a degenerate primer for the PCR detection of human caliciviruses
ES2445495T3 (es) Cebadores de ácido nucleico y sondas para detectar VIH-1 y VIH-2
CN104164488B (zh) 一种单引物引发的核酸恒温扩增方法
AU665952B2 (en) Methods and reagents for hepatitis C detection
KR930008138A (ko) 특정한 뉴클레오티드 시퀀스를 포함하는 약독화(弱毒化)된 홍역 백신 바이러스 균주와 그의 완벽한 동정 방법
DK0806484T3 (da) Syntese af proteiner eller polypeptider kodet af en nucleotidsekvens af HIV-1, HIV-2 eller SIV.
KR870007427A (ko) 증폭 및 하이브리드화로 바이러스를 검출하는 방법
WO2001092572A1 (fr) Ensemble et procede de determination du type de hla
DE69834056D1 (de) De novo oder "universaler" sequenzierungs-array
CA2539703A1 (en) Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays
Zain et al. Preferred site for initiation of RNA transcription by Escherichia coli RNA polymerase within the simian virus 40 DNA segment of the nondefective adenovirus-simian virus 40 hybrid viruses AD2+ ND1 and Ad2+ ND3
KR950701392A (ko) 인체 B형 간염 바이러스에 대한 핵산 증폭 올리고뉴클레오티드 및 프로브(Nucleic Acide Amplification Oligonucleotides and Probes to Human Hepatitis B Birus)
TW329476B (en) Method for detecting contaminant DNA in a protein product and kits used for the same purpose
Clewley et al. Rhabdoviral RNA structure
Legon The binding of ribosomes to polyoma virus RNA: Possible role of the leader region in initiation site recognition
Chow et al. Automated type specific ELISA probe detection of amplified NS3 gene products of dengue viruses.
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
Clewley et al. 2. Existence as a Single, Linear, Covalently-Linked, Single-Stranded Polynucleotide Chain 124
Songsivilai et al. Detection of hepatitis C virus RNA by polymerase chain reaction: Design of amplification primers.
RU97103934A (ru) Способ выявления вируса классической чумы свиней с помощью специфических олигонуклеотидных праймеров и полимеразной цепной реакции
KR950032642A (ko) 신증후성 출혈열 바이러스의 검출방법
Liu et al. Studies on the molecular epidemiology of poliovirus type 1 in China

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19920307

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19920307

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19950630

Patent event code: PE09021S01D

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19950926

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19951229

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19960118

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19960118

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19980908

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19990730

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20001004

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20010803

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20020705

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20030808

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20040810

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20050922

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20060904

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20070724

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20080401

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20090120

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20100125

Start annual number: 16

End annual number: 16

FPAY Annual fee payment

Payment date: 20110927

Year of fee payment: 17

PR1001 Payment of annual fee

Payment date: 20110927

Start annual number: 17

End annual number: 17

EXPY Expiration of term
PC1801 Expiration of term